Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Schwarzschild, Michael
Item TypeName
Academic Article Novel pharmacological targets for the treatment of Parkinson's disease.
Academic Article Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus.
Academic Article Caffeine consumption and risk of dyskinesia in CALM-PD.
Academic Article Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage.
Academic Article Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.
Academic Article Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice.
Academic Article Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease.
Academic Article Targeting adenosine A2A receptors in Parkinson's disease.
Academic Article Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease.
Academic Article Monoamine oxidase B inhibition and neuroprotection: studies on selective adenosine A2A receptor antagonists.
Academic Article Adenosine A2A antagonists as neurotherapeutics: crossing the bridge.
Academic Article Preclinical jockeying on the translational track of adenosine A2A receptors.
Academic Article Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease.
Academic Article Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease.
Academic Article Mice heterozygous for both A1 and A(2A) adenosine receptor genes show similarities to mice given long-term caffeine.
Academic Article Pathophysiological roles for purines: adenosine, caffeine and urate.
Academic Article Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice.
Academic Article Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience.
Academic Article Adenosine A2A receptor gene disruption protects in an a-synuclein model of Parkinson's disease.
Academic Article (E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B.
Academic Article Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
Academic Article Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.
Academic Article Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway.
Academic Article Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia.
Academic Article A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.
Concept Adenosine A2 Receptor Antagonists
Academic Article Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Academic Article Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
Academic Article Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?
Search Criteria
  • Adenosine A2 Receptor Antagonists
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.